The Cancer medicines found to have passed will be re-tested

New Delhi: Delhi government ‘s Drugs Control Dept had taken samples recently to check the quality of medicines. About 75 of them were found to have passed the tests, but the health department is not satisfied with the report. Therefore, preparations are being made to get the samples of these medicines tested again.

Sources in the department say that the government is still suspicious about the tests. Therefore, testing can be done from another lab.

Actually, in the recent past, fake medicines were caught several times in Delhi, which also included medicines used in the treatment of cancer. After this, the Drugs Control Dept officials collected about 160 samples from private medicine shops and pharmacies. Out of these, 127 were cancer medicines. Sources say that the complete report has not come yet, but out of all the medicines whose reports have come, 75 medicines were found to have passed the tests. Now the quality of these medicines found to be correct will be checked again, so that it can be confirmed that the medicines available in the market are completely safe and effective.

For information, let us tell you that a few days ago, the entire chain of the racket which sold a mixture of churan, chalk and food supplements in the form of tablets, capsules and injections as life saving medicines of branded companies is being investigated. The value of the recovered fake medicine consignment has been ascertained from the branded companies, if it was sold as original, the accused would have earned up to Rs 1 crore 5 lakh. The rate of machines used for making and packing fake medicines recovered from the factories has been estimated to be between Rs 40-50 lakh.

Source : Navbharat Times

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?